Enada NADH offers Nutritional Supplement Relief for Chronic Fatigue Syndrome

Georgetown University Medical Center researchers have discovered that Enada NADH, a naturally occurring coenzyme, can alleviate the symptoms of Chronic Fatigue Syndrome (CFIDS/CFS). The complete scientific study will be published in the Annals of Allergy, Asthma & Immunology in February 1999.

The double-blind study conducted at Georgetown University Medical Center found that 31 percent of the patients who took ENADA, a stabilized form of the coenzyme NADH, as a nutritional supplement achieved improvement for the symptoms of CFS, compared to only 8 percnet of the subjects who took a placebo. Subjects who received ENADA NADH took 10 mg. per day.

In a follow-up study, 72 percent of patients saw marked improvement over time. Researchers identified no adverse effects from taking ENADA NADH and no interactions with antidepressants or antihistamines.

NADH occurs in all living cells and plays a central role in the body's energy-producing capacity. NADH's primary responsibility is in the production of human cellular energy - Adenine Triphosphate (ATP). ATP is the cellular "spark" that provides energy from the cell's powerhouse organelle, the mitochondria.

Chronic Fatigue Syndrome is a debilitating disorder with no known cause or cure. More than 600,000 people are afflicted with the disease, and more than 2 million people believe they suffer from chronic fatigue. The primary symptom of CFS/CFIDS is a general, unexplainable lack of energy.

In the past the only treatment readily available combined rest, good nutrition, and light exercise. The results of this study now confirm that ENADA NADH is another treatment offering Chronic Fatigue Syndrome sufferers relief.